Non-viral vectors in cancer gene therapy: principles and progress

Anti-cancer Drugs
Andreas G. Schätzlein

Abstract

This review focuses on the use of synthetic (non-viral) delivery systems for cancer gene therapy. Therapeutic strategies such as gene replacement/mutation correction, immune modulation and molecular therapy/'suicide' gene therapy type approaches potentially offer unique and novel ways of fighting cancer, some of which have already shown promise in early clinical trials. However, the specific and efficient delivery of the genetic material to remote tumors/metastases remains a challenge, which is being addressed using a variety of viral and non-viral systems. Each of these disparate systems has distinct advantages and disadvantages, which need to be taken into account when a specific therapeutic gene is being used. The review concentrates on particulate gene delivery systems, which are formed through non-covalent complexation of cationic carrier molecules (e.g. lipids or polymers) and the negatively charged plasmid DNA. Such systems tend to be comparatively less efficient than viral systems, but have the inherent advantage of flexibility and safety. The DNA-carrier complex acts as a protective package, and needs to be inert and stable while in circulation. Once the remote site has been reached the complex needs to efficiently tra...Continue Reading

References

Sep 1, 1992·Human Molecular Genetics·J A WolffA Jani
Aug 1, 1992·Seminars in Cell Biology·M Stewart
Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·E WagnerM L Birnstiel
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·D T CurielM Cotten
Mar 23, 1990·Science·J A WolffP L Felgner
May 31, 1991·Biochimica Et Biophysica Acta·X H ZhouL Huang
Jan 1, 1990·Electron Microscopy Reviews·C M Feldherr, D Akin
Nov 2, 1990·Biochimica Et Biophysica Acta·G Blume, G Cevc
Jan 26, 1989·Nature·P L Felgner, G M Ringold
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P L FelgnerM Danielsen
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·O BoussifJ P Behr
Aug 11, 1995·The Journal of Biological Chemistry·J ZabnerM J Welsh
Dec 1, 1994·Human Gene Therapy·M A HickmanJ S Powell
May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·M E DowtyJ A Wolff
May 4, 1995·Biochimica Et Biophysica Acta·I Wrobel, D Collins
Jan 1, 1994·Acta Oncologica·A GabizonT Peretz
May 1, 1994·Journal of Cellular Biochemistry·T Boulikas
May 22, 1996·Biochimica Et Biophysica Acta·C D OjaP R Cullis
Apr 1, 1996·Critical Reviews in Biochemistry and Molecular Biology·N Panté, U Aebi
Oct 29, 1996·Proceedings of the National Academy of Sciences of the United States of America·K A Mislick, J D Baldeschwieler
Dec 27, 1996·The Journal of Biological Chemistry·B A SosnowskiA Baird
Feb 1, 1997·Experimental Cell Research·D A Dean
Jan 1, 1997·Bioconjugate Chemistry·M S WadhwaK G Rice
Mar 20, 1997·Human Gene Therapy·P L FelgnerG Wu

❮ Previous
Next ❯

Citations

Feb 5, 2003·Journal of Biomedical Science·Ian F Parney, Lung-Ji Chang
Jan 14, 2005·Archives of Pharmacal Research·Na Hyung KimHwa Jeong Lee
Aug 13, 2011·Pharmaceutical Research·Volkmar Weissig
Apr 15, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ernst WagnerGreg F Walker
Jun 11, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·S GoverdhanaM G Castro
Mar 6, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·James W YockmanSung Wan Kim
Oct 18, 2001·International Journal of Pharmaceutics·M D BrownI F Uchegbu
Aug 15, 2002·International Journal of Pharmaceutics·Emmanuelle RouxJean-Christophe Leroux
Mar 26, 2003·Seminars in Cancer Biology·Irina V LebedevaPaul B Fisher
Mar 5, 2003·Trends in Molecular Medicine·Gabriele D Schmidt-Wolf, Ingo G H Schmidt-Wolf
Apr 10, 2002·Immunology and Cell Biology·Chee-Kai Chan, David A Jans
Nov 18, 2009·Biochemistry. Biokhimii︠a︡·D G ShcharbinM Bryszewska
Aug 25, 2007·Nanomedicine·Raymond M SchiffelersGert Storm
Jan 30, 2002·Analytical Biochemistry·Philippe ReynierEliane Taillandier
Nov 30, 2013·International Journal of Pharmaceutics·D IbraheemH Fessi
Apr 29, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Sridevi GorleMoganavelli Singh
Oct 1, 2005·Journal of Liposome Research·Martin BartschJan A A M Kamps
Aug 8, 2006·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Pascal DammeyerDavid T Harris
Oct 14, 2014·Expert Review of Vaccines·Samantha L KurtzDavid A Zaharoff
Apr 15, 2014·Polymers·Ian Teasdale, Oliver Brüggemann
Dec 13, 2006·Journal of Drug Targeting·Hocine SlimaniAn Cao
Oct 28, 2004·Journal of Drug Targeting·Julia KloecknerErnst Wagner
Dec 5, 2009·Journal of Drug Targeting·Lourena Mafra VerissimoE Sócrates Tabosa do Egito
Oct 19, 2010·Drug Development and Industrial Pharmacy·Soo Hyun JangHwa Jeong Lee
Apr 1, 2003·The Journal of Gene Medicine·Martin L ReadLeonard W Seymour
Oct 11, 2011·Acta Biomaterialia·Jun HuThomas Armin Fuchsluger
Jul 8, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·S G L QuaakB Nuijen
Jul 10, 2010·Journal of Biomedicine & Biotechnology·Syahril AbdullahAbraham J Domb
Dec 16, 2006·Ultrasound in Medicine & Biology·Chun-Yen LaiPai-Chi Li
Oct 1, 2010·Advanced Materials·Sonja BauhuberAchim Göpferich
Dec 22, 2007·Angewandte Chemie·Viktoriya Sokolova, Matthias Epple
Nov 17, 2006·Journal of Biomedical Materials Research. Part a·Ankit AgarwalSurya K Mallapragada
Feb 1, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Claudia StrehblowJean Bernhard Petri
Dec 14, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Andreas G SchatzleinIjeoma F Uchegbu
May 26, 2004·International Journal of Pharmaceutics·A PercotA Cao

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Advanced Drug Delivery Reviews
J Zabner
Journal of the National Cancer Institute
Renee Twombly
Colloids and Surfaces. B, Biointerfaces
Ayşe Gönen Karakeçili, Menemşe Gümüşderelioğlu
© 2021 Meta ULC. All rights reserved